Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites

Intern Med. 2022 Nov 1;61(21):3225-3231. doi: 10.2169/internalmedicine.9266-21. Epub 2022 Apr 2.

Abstract

Oxaliplatin, widely used as a chemotherapy drug for colorectal cancer, is known to cause various adverse reactions. In particular, special attention for the development of portal hypertension associated with porto-sinusoidal vascular disease is necessary, as it is a serious adverse life-threating reaction, although rare. We herein report a case of oxaliplatin-related portal hypertension that developed several years after oxaliplatin administration and led to esophageal varices and refractory massive ascites. Clinical physicians should be aware of the possibility of oxaliplatin-induced portal hypertension and its possible development over a long period after discontinuation of the drug.

Keywords: esophageal varices; oxaliplatin; portal hypertension; porto-sinusoidal vascular disease; refractory ascites.

Publication types

  • Case Reports

MeSH terms

  • Ascites / complications
  • Esophageal and Gastric Varices* / complications
  • Gastrointestinal Hemorrhage / complications
  • Humans
  • Hypertension, Portal* / chemically induced
  • Hypertension, Portal* / complications
  • Oxaliplatin / adverse effects
  • Vascular Diseases* / complications

Substances

  • Oxaliplatin